NO20016224D0 - Pharmaceutical composition containing sibutramine and orlistat - Google Patents

Pharmaceutical composition containing sibutramine and orlistat

Info

Publication number
NO20016224D0
NO20016224D0 NO20016224A NO20016224A NO20016224D0 NO 20016224 D0 NO20016224 D0 NO 20016224D0 NO 20016224 A NO20016224 A NO 20016224A NO 20016224 A NO20016224 A NO 20016224A NO 20016224 D0 NO20016224 D0 NO 20016224D0
Authority
NO
Norway
Prior art keywords
orlistat
pharmaceutical composition
composition containing
containing sibutramine
sibutramine
Prior art date
Application number
NO20016224A
Other languages
Norwegian (no)
Other versions
NO20016224L (en
Inventor
David John Heal
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20016224D0 publication Critical patent/NO20016224D0/en
Publication of NO20016224L publication Critical patent/NO20016224L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016224A 1999-06-24 2001-12-19 Pharmaceutical composition containing sibutramine and orlistat NO20016224L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914744.9A GB9914744D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005542 WO2001000205A1 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and orlistat

Publications (2)

Publication Number Publication Date
NO20016224D0 true NO20016224D0 (en) 2001-12-19
NO20016224L NO20016224L (en) 2002-02-12

Family

ID=10855955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016224A NO20016224L (en) 1999-06-24 2001-12-19 Pharmaceutical composition containing sibutramine and orlistat

Country Status (21)

Country Link
EP (1) EP1187606A1 (en)
JP (1) JP2003503349A (en)
KR (1) KR20020015357A (en)
CN (1) CN1358092A (en)
AU (1) AU5533200A (en)
BG (1) BG106180A (en)
BR (1) BR0011880A (en)
CA (1) CA2375972A1 (en)
CZ (1) CZ20014613A3 (en)
GB (1) GB9914744D0 (en)
HK (1) HK1049278A1 (en)
HU (1) HUP0201878A3 (en)
IL (1) IL147079A0 (en)
MX (1) MXPA01012936A (en)
NO (1) NO20016224L (en)
PL (1) PL352402A1 (en)
RU (1) RU2229289C2 (en)
SK (1) SK18242001A3 (en)
TR (1) TR200103699T2 (en)
WO (1) WO2001000205A1 (en)
ZA (1) ZA200109989B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696495B2 (en) * 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
AU2005298692A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions
EP2066329B1 (en) 2006-09-15 2017-09-06 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cyclobutylmethylamines
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
KR20080046601A (en) * 2006-11-22 2008-05-27 에스케이케미칼주식회사 Inclusion complex of sibutramine and beta-cyclodextrin
CN101890017A (en) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 Medicament composition containing sibutramine and stanin fat-reducing medicament and application thereof
MX336980B (en) 2010-12-21 2016-02-09 Senosiain S A De C V Lab Combination and composition for treating obesity.
WO2013102195A1 (en) 2011-12-30 2013-07-04 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727131D0 (en) * 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
BG106180A (en) 2002-08-30
HK1049278A1 (en) 2003-05-09
CN1358092A (en) 2002-07-10
MXPA01012936A (en) 2004-04-21
ZA200109989B (en) 2003-02-26
SK18242001A3 (en) 2003-02-04
RU2229289C2 (en) 2004-05-27
CZ20014613A3 (en) 2003-04-16
AU5533200A (en) 2001-01-31
IL147079A0 (en) 2002-08-14
CA2375972A1 (en) 2001-01-04
GB9914744D0 (en) 1999-08-25
KR20020015357A (en) 2002-02-27
EP1187606A1 (en) 2002-03-20
PL352402A1 (en) 2003-08-25
HUP0201878A3 (en) 2005-04-28
HUP0201878A2 (en) 2003-08-28
BR0011880A (en) 2002-03-19
JP2003503349A (en) 2003-01-28
NO20016224L (en) 2002-02-12
TR200103699T2 (en) 2002-04-22
WO2001000205A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
NO20001651L (en) Downloading data
DK1454907T3 (en) Quninazoline and pyridopyrmidine derivatives
DK1233964T3 (en) New use and novel N-azabicycloamide derivatives
DK1112174T3 (en) Isosorbide-containing polyesters and processes for their preparation
DE69840172D1 (en) RNA EXPORTELEMENT
NO20032753L (en) Compound and Use thereof
DE69928195D1 (en) Completion of Untrerdruck-boreholes
DE69805692T2 (en) watchband
PT1034144E (en) PROTECTED GLASS
DK199900820A (en) Earrings
DK1300129T3 (en) Implant vial
NO20000057L (en) coring
PT869121E (en) PROPANOLAMINE HIPOLIPIDEMIC DERIVATIVES
ATE357237T1 (en) FORMULATIONS CONTAINING CEFUROXIM-AXETIL
DE19882595T1 (en) Trinket
DE59806331D1 (en) hollow jewelery
NO20016224L (en) Pharmaceutical composition containing sibutramine and orlistat
DK0910369T3 (en) Benzothiophenes, formulations containing the same and methods
FI102647B1 (en) Programmable amplifier
DK1140952T3 (en) Phosphorus-organic compounds and their use
DE19881428D2 (en) Funny gyros toy
KR980000831U (en) bracelet
KR960036347U (en) bracelet
KR970053606U (en) Golf Wristbands
UA3147S (en) LABEL OF COGNAC

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application